Brief: Amniotics Q4 Operating Loss Narrows To SEK 9.8 Million
19/01/2023 07:05
Jan 19 (Reuters) - Amniotics AB (publ) AMNI.ST :
* Q4 OPERATING LOSS (EBITDA): SEK -9.8 (-13.2) MILLION.
* Q4 RESULT FOR PERIOD: SEK -10.9 (-13.2) MILLION.
Source text for Eikon: ID:nMFN2r0YsJ
Further company coverage: AMNI.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Amniotics AB (publ)
See all newsBrief: Swedish Companies Registration Office Authorises Magle Group, Amniotics Merger Plan
Brief: Amniotics H1 Net Revenue SEK 2.5 Million
Brief: Amniotics Gets Conditional Approval To Delist From Nasdaq First North Growth Market
Brief: Amniotics To Delist From Nasdaq First North Growth Market Upon Magle Group Merger Completion
Brief: Magle Chemoswed, Amniotics Adopt Merger Plan